The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist: A systematic review and meta-analysis

BACKGROUND: Infliximab (IFX) and adalimumab (ADA) refer to the classic drugs to treat moderate-severe inflammatory bowel disease (IBD), which have been proven to be effective to control IBD. However, the side effects exerted by IFX and ADA should be monitored in therapies, especially the paradoxical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Meiqi, Liu, Weixin, Deng, Qiuping, Liang, Zeng, Wang, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542134/
https://www.ncbi.nlm.nih.gov/pubmed/34678884
http://dx.doi.org/10.1097/MD.0000000000027510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542134/
https://www.ncbi.nlm.nih.gov/pubmed/34678884
http://dx.doi.org/10.1097/MD.0000000000027510

Ejemplares similares